We are live on
!
Find out more
AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
37.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.83%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$288M
AUM Growth
+$11.3M
(+4.1%)
Cap. Flow
-$1.59M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
61.3%
Holding
95
New
4
Increased
57
Reduced
8
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$2.61M |
| 2 |
Microsoft
MSFT
|
+$1.81M |
| 3 |
Global Payments
GPN
|
+$1.78M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$1.37M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$951K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$7.03M |
| 2 |
SHPG
Shire pic
SHPG
|
+$2.89M |
| 3 |
Gilead Sciences
GILD
|
+$2.4M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$1.54M |
| 5 |
Murphy Oil
MUR
|
+$1.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.61% |
| 2 | Energy | 17.8% |
| 3 | Industrials | 17.78% |
| 4 | Technology | 10.38% |
| 5 | Financials | 6.71% |
Similar funds
SC
EF
PI
NAAA
GA
GHA
BCM
MA
Aristotle Atlantic Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Aristotle Atlantic Partners held 95 positions worth $288M, up 4.1% from $277M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Aristotle Atlantic Partners's Q2 2018 filing shows 4 new, 57 increased, 8 reduced and 12 closed positions. Its largest new stake was Sage Therapeutics: 8,700 shares worth $1.36M. The largest sale was Monsanto Co, an estimated $7.03M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 34% a quarter earlier, followed by Energy and Industrials.
- Aristotle Atlantic Partners's largest Q2 2018 buy was Sage Therapeutics: 8,700 shares worth $1.36M.
- Aristotle Atlantic Partners added most to Bio-Techne in Q2 2018, an estimated $2.61M increase.
- Aristotle Atlantic Partners's biggest Q2 2018 reduction was Gilead Sciences, cutting an estimated $2.4M.
- Aristotle Atlantic Partners fully exited Monsanto Co in Q2 2018, selling an estimated $7.03M.
- Aristotle Atlantic Partners's ten largest holdings make up 61% of its $288M portfolio in Q2 2018.
- Aristotle Atlantic Partners opened 4 new positions and closed 12 in Q2 2018.
- Aristotle Atlantic Partners's portfolio value rose 4.1% quarter-over-quarter to $288M.
Based on Aristotle Atlantic Partners's 13F filing for Q2 2018, filed 14 Aug 2018.